Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Cipla, India and Eli Lilly

Digest more
 · 3d · on MSN
Eli Lilly allows Cipla to sell weight loss drug under new brand in India
Eli Lilly signed an agreement with Cipla, allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate brand in the country, the companies said on Thursday. Under the agreement,

Continue reading

 · 3d
Cipla shares fall 3% after Eli Lilly deal to market weight-loss drug in India: Here's what analysts say
 · 3d
Cipla to market Eli Lilly’s weight loss and diabetes drug Mounjaro in India, under a different brand name
9don MSN

Eli Lilly, Novo Nordisk Stocks Drop. Trump Targets Ozempic, ‘Fat Loss’ Drug Prices.

Trump told reporters late Thursday that the list price of Ozempic, which he called “the fat loss drug,” will be “much lower.” ...
Blockonomi
9d

Novo Nordisk and Eli Lilly Stocks Fall After Trump Announces Weight-Loss Drug Price Cuts

Novo Nordisk and Eli Lilly stocks fell after Trump announced Ozempic prices could drop to $150 monthly from $1,000.
2don MSN

UK seizes record haul of illegal weight-loss drugs in factory raid

Britain's medicines regulator said on Friday it had made the world's largest seizure of unlicensed weight-loss medicines, ...
Axios on MSN
5d

How Eli Lilly became the new king of GLP-1s

Eli Lilly is poised to leapfrog Novo Nordisk and become the dominant player in an anti-obesity drug market that could reach ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms